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Abstract: We demonstrate, for the first time, the multiplexed
determination of microbial species from whole blood using the
paper-folding technique of origami to enable the sequential
steps of DNA extraction, loop-mediated isothermal amplifica-
tion (LAMP), and array-based fluorescence detection. A low-
cost handheld flashlight reveals the presence of the final DNA
amplicon to the naked eye, providing a “sample-to-answer”
diagnosis from a finger-prick volume of human blood, within
45 min, with minimal user intervention. To demonstrate the
method, we showed the identification of three species of
Plasmodium, analyzing 80 patient samples benchmarked
against the gold-standard polymerase chain reaction (PCR)
assay in an operator-blinded study. We also show that the test
retains its diagnostic accuracy when using stored or fixed
reference samples.
Nucleic acid based tests (NATs) offer the promise of
microbial diagnostics, determining either the species present
or characteristics of the pathogen, such as drug resistance. The
gold-standard assay used in many reference laboratories is
based upon a polymerase chain reaction (PCR) amplifica-
tion—a technology which achieves high sensitivities but
which also requires trained staff and external power. In
contrast, identification of microbial species in resource-
limited environments requires low cost, simple tests that do
not need external or fixed power supplies. One example
where such a simple low-cost test could transform outcomes is
in malaria diagnosis, where species identification directly
informs patient treatment.
Classical malaria diagnosis involves a blood smear fol-
lowed by microscopy, which, although simple, does not
provide the required sensitivity and only enables species
specific information in the hands of trained experts.[1] New
approaches will be required to tackle the disease, where
asymptomatic individuals commonly harbor the disease at
levels that are below the sensitivity of microscopy (< 100 par-
asites/mL).[2] Nucleic acid based tests (NATs) offer the
promise of achieving such high sensitivities (1 parasite/mL)
with excellent specificity,[3] enabling healthcare professionals
to inform treatment.[4]
As many people living at risk of malaria infection have no
access to diagnosis, presumptive treatment of all febrile
patients as if they were malaria cases is a common practice,
which has become a serious problem, especially in sub-
Saharan Africa.[5] Currently, the most widely adopted NAT
method in infectious disease diagnosis is still PCR, although
the reliance on thermocycling has proven a barrier to its
implementation in low-resource settings.[6] LAMP has
emerged as a low-cost alternative,[7] simplifying hardware
requirements whilst enabling visual detection.[8] Although
amenable to multiplexing, the high number of primers
required (up to six per target)[9] restricts the number of
targets that tests can detect in one reaction. A commercial
Plasmodium genus LAMP test is available, but the system
requires a multi-step DNA extraction based on the PURE
methodology, carried out on a bench-top instrument. Alter-
natively, lateral flow tests, commonly referred to as “rapid
diagnostic tests” (RDT), also exist,[10] but their sensitivity is
poor.[11]
Herein, we show a new capillary-flow platform that
combines ease-of-use and low-cost with the sensitivity of
LAMP, into a multiplexed three taxon-specific test plus
a control. We overcome the difficulties linked to sample
preparation and multiplexing using capillary wicking and
paper-folding origami techniques to distribute fluids both
vertically and laterally.[12,13]
Previously paper microfluidics (see Review[14]) has ena-
bled single units of a NAT, such as DNA extraction,[15] DNA
isothermal amplification,[16] which have been integrated into
a manual “machine”[17] with hybridization-based DNA detec-
tion.[18] We now integrate all the required steps into a single
device to detect Plasmodium falciparum, Plasmodium
vivax,[19] and Plasmodium pan directly from a finger-prick
volume of whole blood within an operator-blinded study
(Figure 1).
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Often in-field testing cannot be performed for logistical
reasons, and retrospective diagnosis is required. Testing of
archived blood samples is also important for epidemiologists
to re-visit reference samples or to analyze historical data
sets.[20] We therefore show that we can identify parasites in
preserved samples of frozen whole blood, as thick and thin
fixed smear samples on glass slides, and as whole blood dried
onto paper.
The fabrication of the device using wax printing,[21] as well
as the operating steps, shown in Figure 1 and Figure 2, are all
detailed in the Supporting Information. After addition of the
sample onto the device (Panel 3, Figure 2A), the paper was
folded (structure S1, Figure 2B) to enable the first steps of the
assay, involving cell lysis and DNA extraction, to yield
purified DNA (Figure 2B–D) on the glass-fiber paper. To
transfer the DNA from the extraction panel to the amplifi-
cation panel, the fold S1 is flipped on the opposite side
(Figure 2E), allowing elution (Panels 4–5 of Figure 2A
and F). Supporting Information Figure S1(A) illustrates the
extraction process.
Multiplexing analysis was enabled by using capillarity to
guide the sample to four independent locations on the paper
within hot wax printed channels, where species-specific
LAMP reagents were deposited (Figure 2A, panel 5). The
system was sealed by an acetate film to prevent evaporation
during incubation (Figure 1B and D) and amplification was
carried out 63 8C for up to 45 min on a simple hotplate. The
results of species-specific LAMP were initially read-out by
the naked eye with a handheld UV lamp (365 nm; Fig-
ure 3A).[8]
We also showed that the technique was amenable to
quantification (Figure 3B,C). To test sensitivity, we used the
WHO International Standard for P. falciparum DNA,[22]
which was serially diluted from 10 to 104 times. The real-
time amplification curves (Figure 3B) were nor-
malized to 1 for ease of comparison and show that
sensitivity down to 105 IU/mL can be achieved
within 35 min. As the copy number decreases, so
the exponential phase of signal enhancement
starts later (Figure 3C) as a consequence of
diffusion limited reaction kinetics. For highly
infected samples, the time to detection can be
significantly faster, down to 12 min for 108 IU/mL.
80 fully characterized fresh (unfrozen) EDTA-
blood samples from the PHE MRL were then
tested by origami-LAMP in an operator-blind
experiment.
Our method showed high specificity and good
sensitivity for identifying Plasmodium in blood
samples (Table 1), when compared against the
benchmark PCR.[3, 24] Only for P. falciparum was
sensitivity below 80%, as a number of samples for
this species were of low parasite density.
All samples were also tested with a commer-
cially-available LAMP kit for malaria (Eiken
Chemical Company Ltd. (Japan)), which covers
two of our three targets (Plasmodium pan and
P. falciparum ; Table 2). The specificity for Plas-
Figure 1. Paper-based multiplexed LAMP detection of malaria in blood. A) Foldable
paper devices: Dark areas are printed with hydrophobic wax. The device consists of
five panels (1–5) folding onto each other, and a plastic cover for LAMP processing
to avoid evaporation (B). The design also incorporates alignment marks on two
corners (in the bottom left and top right corners) to assign the results. C) Illustrates
the extraction process. Panels 2 and 3 are folded together and onto Panel 1. The
sample is dispensed onto the device (panel 3) and extracted using capillary flows
vertically (flow of liquid from Panel 3 to Panel 1). By folding the device (flipping the
Panel 2–3 fold onto Panels 4 and 5), the sample is transferred to the LAMP
spots (D) where the reaction is carried out. The signal is read out using a UV
flashlight (365 nm; E).
Figure 2. Paper-folding steps for fluidic manipulation of assay steps.
The broken arrows indicate folding direction. Panels numbered as in
Figure 1. A) A hole from the center of the third Panel has a glass-fiber
disc onto which the sample is dispensed; Numbers in the last panel
indicate the different reagents placed onto the four different spots for
amplification of different species. 1. Internal control (IC); 2. Plasmo-
dium pan; 3. P. falciparum; 4. P. vivax. B) The second/third Panel are
folded and clamped to form structure 1 (S1); C) The fifth Panel is
folded onto the back of the fourth frame to form structure 2 (S2);
D) S1 is folded onto the first Panel before adding lysis/washing buffer
for DNA extraction and purification; E–F) S1 is folded onto S2 for
elution and elution buffer added.
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modium pan and P falciparum between our method and the
LAMP kit, which deploys readout in a commercial turbidim-
eter, were above 98%, while sensitivity was lower at 88 and
69% respectively (Table 2).
Compared to the commercial LAMP kit, our platform has
two advantages: origami LAMP is able to differentiate
between P. falciparum and P. vivax infection, and correctly
identify non-vivax/ non-falciparum, while also providing pan-
genus diagnosis as a single test. This has implications in
guiding case management since these two species are
associated with different treatments.[25, 26] P. falciparum is
more likely to progress to a severe illness than P vivax,
while P. vivax requires treatment of the dormant form of the
parasite. The two species also present different drug resist-
ance profiles.[26] The inclusion of an internal control is an
important quality control element for ruling out false
negatives due to test failure.
Our method is more sensitive than microscopy and
showed a close coincidence with both the gold standard
benchmark (PCR) and a commercial LAMP assay (> 90%,
except for the PCR P. pan assay, 88%—detailed calculations
in Table S1). The origami LAMP test only failed to detect
seven weakly positive samples. These included PCR-positive
individuals with negative blood films, and patients that had
already commenced antimalarial treatment. Importantly, if
we exclude these challenging samples from the test panel, the
sensitivity increases to 100% for P. falciparum and 95% for
P. pan, while coincidence with other methods reach above
93% for all assays.
We also studied the analytical sensitivity of the technique
using serially diluted cultured samples in whole blood,
demonstrating detection down to 5 parasites/ml (a threshold
below that of routine microscopy and below the clinical
threshold at which symptoms of malaria occur, 500 parasites/
mL[27]—see Methods and Figures S2-3 in the Supporting
Information). Clinically, this allows any user to consider
that a negative test in a febrile patient will be indicative of the
fact that malaria infection is not the cause of the fever,
although the presence of a low density parasitaemia of
Plasmodium spp. cannot be ruled out. Of particular impor-
tance is that the high specificity of our method, and thus low
false positive ratio, gives the user confidence that a positive
result truly indicates the presence of malaria.
To analyze samples retrospectively, we stored 4 blood
samples under four different conditions (frozen, as thick and
thin smears fixed in acetone, and dried). Table S2 shows that
there is no difference between using frozen and fresh samples
(Figure S4 shows the details of the images obtained), enabling
retrospective analysis when testing in the field is not possible
Figure 3. Results of multiplex LAMP amplification under UV light.
Under UV excitation, green calcein emission occurs in the presence of
pyrophosphate A) Numbers denote different species-specific LAMP
reaction. 1. Internal control (IC); 2. Plasmodium pan; 3. P. falciparum ;
4. P. vivax. Letters denote the different positive results: a. 1 positive;
b. 1 and 2 positive; c. 1, 2 and 3 positive; d. all positive. B) Real-time
amplification curve of Plasmodium pan LAMP with the 10-fold serially
diluted target (1–4, normalized real-time amplification curves), and
ddH2O as a negative control (5): 1. 10
8 IU/mL (red up-triangle);
2. 107 IU/mL (green right-triangle); 3. 106 IU/mL (cyan down-triangle);
4. 105 IU/mL (magenta circle). 5. Negative control (black square: no
target DNA). As the concentration increases, the amplification is
initiated earlier, evidenced by the exponential increase in the fluores-
cence. C) Threshold time (defined as the time corresponding to 50%
of the maximum fluorescence intensity, Tt) as a function of target
concentration. This Figure of merit is analogous to the cycle threshold
(Ct) of real-time PCR.[23] Data is the average of three repeats and error
bars represent the standard deviation. The data was fitted with linear
regression (R2=0.98).
Table 1: The diagnostic accuracy for multiplex-LAMP against reference
laboratory diagnosis (using PCR as a benchmark).
Origami LAMP Sensitivity Specificity
Positive Negative
Benchmark PCR
P. falciparum
Pos 11 7
61% 98%
Neg 1 61
P. ovale spp./
P. malariae
Pos 27 2
93% 96%
Neg 2 49
P. vivax
Pos 17 4
81% 98%
Neg 1 58
Any Plasmo-
dium spp.
Pos 59 10
86% 100%
Neg 0 11
Table 2: Species-specific malaria diagnosis by commercial LAMP and
origami-LAMP.
Origami LAMP Sensitivity Specificity
Positive Negative
Commercial LAMP
P. falciparum
Pos 11 5
69% 98%
Neg 1 63
Any Plasmo-
dium spp.
Pos 60 8
88% 100%
Neg 0 12
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or in large cross-sectional studies.[28] As an additional feature
of paper-based devices for disease diagnostics, we noted that
samples can be readily disposed of by incineration.[29]
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